Trials / Completed
CompletedNCT01035021
Neuromuscular Block in Laryngeal Mask Airway(LMA) Insertion
Effect of Neuromuscular Blockade on the Insertion of ProSeal™ Laryngeal Mask Airway and Postoperative Pharyngolaryngeal Discomfort
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the success rate, insertion time and complication depending on the use of neuromuscular blocking agent when inserting the laryngeal mask airway (LMA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | use of rocuronium when the LMA is inserted | Anesthesia is induced with a propofol and remifentanil in both groups, however rocuronium 0.06 mg/kg is injected only in group R. Insertion of LMA is performed by the standard technique according to the manufacturer's instruction. In group N, rocuronium is administered for the operation. |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2009-12-18
- Last updated
- 2013-11-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01035021. Inclusion in this directory is not an endorsement.